<qa>  What is the phase I dose-escalation study of bortezomiOUTLINE: This is a phase I dose-escalation study of bortezomib followed by a phase II randomized, multicenter study. Patients in phase II are stratified according to disease mantle cell lymphoma vs indolent B-cell lymphoproliferative disorder vs transformed lymphoma. 